Literature DB >> 23643854

Hepcidin-25: Measurement by LC-MS/MS in serum and urine, reference ranges and urinary fractional excretion.

Fleur Wolff1, Marie Deleers, Christian Melot, Béatrice Gulbis, Frédéric Cotton.   

Abstract

A liquid chromatography tandem-mass spectrometry (LC-MS/MS) method was developed for reliably quantifying hepcidin-25 in human urine and serum. A 95% reference range was established for serum hepcidin-25 levels by standardizing the sampling time between 8:00am and 11:00am in 90 apparently healthy volunteers. The association between hepcidin-25 concentration and other biological parameters was studied using multivariable analysis and the coefficient of renal excretion of hepcidin-25 was calculated. Preanalytical variables were also investigated. The LC-MS/MS method was validated using a recent validation strategy based on accuracy profiles. Good results were obtained in terms of trueness, precision, and linearity in the following dosing ranges: from 0.77 to 200nmol/L for urine and from 0.48 to 100nmol/L for serum. The 95% reference range of serum hepcidin-25 concentration established after excluding known conditions that affect hepcidin-25 expression was 1.5 to 15.2nmol/L. A difference between genders was demonstrated with a median concentration of 5.5 versus 7.2nmol/L for women and men, respectively. Serum hepcidin-25 concentrations were strongly correlated with ferritin and, to a lesser extent, with iron levels. The coefficient of renal excretion ranged from 0.1 to 16.4%. Higher values of hepcidin-25 concentrations were observed on ethylene diamine tetraacetate tubes compared to serum or lithium-heparin devices.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23643854     DOI: 10.1016/j.cca.2013.04.021

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  6 in total

Review 1.  Modulation of hepcidin to treat iron deregulation: potential clinical applications.

Authors:  Nicole L Blanchette; David H Manz; Frank M Torti; Suzy V Torti
Journal:  Expert Rev Hematol       Date:  2015-12-15       Impact factor: 2.929

Review 2.  Out of balance--systemic iron homeostasis in iron-related disorders.

Authors:  Andrea U Steinbicker; Martina U Muckenthaler
Journal:  Nutrients       Date:  2013-08-02       Impact factor: 5.717

Review 3.  Laboratory use of hepcidin in renal transplant recipients.

Authors:  Lucija Šimetić; Lada Zibar
Journal:  Biochem Med (Zagreb)       Date:  2016       Impact factor: 2.313

4.  Serum Concentration of Hepcidin as an Indicator of Iron Reserves in Children.

Authors:  Jelena Ćulafić; Jovanka Kolarović; Lato Pezo; Velibor Čabarkapa; Stanislava Nikolić; Aleksandra Stojadinović; Marija Bodroža Solarov
Journal:  J Med Biochem       Date:  2018-12-01       Impact factor: 3.402

5.  Evaluation of a commercial liquid-chromatography high-resolution mass-spectrometry method for the determination of hepcidin-25.

Authors:  Dietmar Enko; Sieglinde Zelzer; Günter Fauler; Markus Herrmann
Journal:  Biochem Med (Zagreb)       Date:  2019-04-15       Impact factor: 2.313

6.  Hepcidin as a Sensitive and Treatment-Responsive Acute-Phase Marker in Patients with Bacteremia: A Pilot Study.

Authors:  Kreon Koukoulas; Vasiliki Lygoura; Philip Kartalidis; Nikolaos K Gatselis; Efthymia Petinaki; George N Dalekos; George Simos
Journal:  Diagnostics (Basel)       Date:  2022-06-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.